Anika Therapeutics | ANIK - Capital Ordinaire





Capital Ordinaire Changement Date
Abbott USD 1.74B 2.94M 2026-03
Agenus USD 38.52M 3.2M 2026-03
Agios Pharmaceuticals USD 59.6M 264K 2026-06
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 141.14M 564K 2026-06
Enanta Pharmaceuticals USD 212K 1000 2023-12
Halozyme Therapeutics USD 113.94M 106K 2026-09
Heron Therapeutics USD 188.31M 4.99M 2025-12
Insmed USD 218.28M 1.76M 2026-06
Integra LifeSciences USD 77.78M 39K 2026-06
Intrexon USD 0 0 2024-06
J&J USD 2.41B 1.64M 2026-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
MacroGenics USD 63.65M 86K 2026-06
Merit Medical Systems USD 59.71M 55K 2026-06
Rigel Pharmaceuticals USD 17K 158K 2024-06
Sanofi EUR 1.2B 0 2026-09
Smith & Nephew USD 875.95M 11.64K 2026-06
Stryker USD 383.4M 416K 2026-06
Veracyte USD 80.39M 598K 2026-09
Xencor USD 74.33M 265K 2026-06
Zimmer Biomet Holdings USD 190.1M 3.3M 2026-09